KNSA

Kiniksa Pharmaceuticals Internat…

75.34

-0.74-0.97%

After Hours: 75.34 0.00 0.00%16:15 09/24 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE75.32/76.10

TODAY RANGE74.33-76.52

VOL620.70K

MARKET CAP5.91B

52 WEEK RANGE35.20-82.94

AVG VOL (3M)606.69K

% TURNOVER0.29%

TURNOVER--

P/E (TTM)77.06

% RANGE2.88%

EPS(TTM)0.9828

P/E(FORWARD)60.01

P/B9.03

BVPS8.38

DIVIDEND--

P/S8.53

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP3.49B

SHARES OUTSTANDING78.02M

NEXT EARNINGS10/26-10/30

FREE FLOAT46.15M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

NASDAQ·09/17 16:13
Kiniksa Pharmaceuticals Stock Rallies 41% in Three Months: Here's Why
TipRanks·08/13 12:50
Analysts Are Bullish on Top Healthcare Stocks: Kiniksa Pharmaceuticals (KNSA), REPRO-MED Systems (KRMD)
TipRanks·08/01 02:02
Insider Shake-Up at Kiniksa Pharmaceuticals Sparks Investor Buzz
Dow Jones·07/30 18:53
Kiniksa Pharmaceuticals Price Target Raised to $90.00/Share From $75.00 by Goldman Sachs
Dow Jones·07/30 18:53
Kiniksa Pharmaceuticals Is Maintained at Buy by Goldman Sachs
NASDAQ·07/30 16:20
Earnings Estimates Rising for Kiniksa Pharmaceuticals International, plc (KNSA): Will It Gain?
TipRanks·07/30 06:00
Lack of Disclosure on Unregistered Equity Sales Clouds Dilution Risks at Kiniksa Pharmaceuticals
Dow Jones·07/29 18:40
Kiniksa Pharmaceuticals Is Maintained at Overweight by JP Morgan
Dow Jones·07/29 18:40
Kiniksa Pharmaceuticals Price Target Raised to $107.00/Share From $72.00 by JP Morgan
Dow Jones·07/29 17:54
Kiniksa Pharmaceuticals Price Target Raised to $98.00/Share From $64.00 by Canaccord Genuity
Dow Jones·07/29 17:54
Kiniksa Pharmaceuticals Is Maintained at Buy by Canaccord Genuity
Dow Jones·07/29 17:03
Kiniksa Pharmaceuticals Is Maintained at Outperform by Wedbush
Dow Jones·07/29 17:03
Kiniksa Pharmaceuticals Price Target Raised to $99.00/Share From $72.00 by Wedbush
Dow Jones·07/29 13:50
Kiniksa Pharmaceuticals Price Target Raised to $100.00/Share From $60.00 by Citigroup
Dow Jones·07/29 13:50
Kiniksa Pharmaceuticals Is Maintained at Buy by Citigroup

Same Industry

Name/Symbol

Change%

Price

Kiniksa Pharmaceuticals International, plc

KNSA

-0.97%

75.34

McKesson

MCK

-0.31%

866.64

Biogen Inc

BIIB

-1.62%

215.50

Amgen Inc

AMGN

+1.55%

385.65

SHPG

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

+7.67%

0.1249

Lilly Eli & Co

LLY

+1.04%

Celgene

CELG

0.00%

108.24

TXMD

Johnson & Johnson

JNJ

-0.09%

269.99

ABBV

Zoetis Inc

ZTS

-0.74%

70.87

Gilead Sciences Inc

GILD

-0.52%

150.11

NVO

Bristol-Myers Squibb Co

BMY

+0.35%

63.06

Alexion Pharms

ALXN

+1.70%

182.50

PFE

Sanofi FR

SNY

+0.42%

41.11

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

-0.39%

140.37

Dr Reddys Labs

RDY

0.00%

12.19

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.